Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

(Reuters) - A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has ...

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

HYDERABAD, India (Reuters) - Indian pharmaceutical companies will be able to retain their dominant market share in the U.S.

Novo Nordisk is growing its India-based global business services to fill out vertical stacks, expand horizontal functions, ...

Denmark’s astronaut accuses Elon Musk of lying. This leads Musk to call Mogensen “an idiot”.The argument is based on a recent interview on Fox News, where Musk is interviewed together with Donald ...

The Danish government has reached an agreement to make egg donation more accessible, reducing wait times for fertility treatment.  The changes will take effect on January 1st 2026, following a change ...

Kenyan researchers are spearheading the development of a groundbreaking dietary supplement that could revolutionise maternal and child health across the world.The project, named ‘Mother’s ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

(Reuters) - Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage ...

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best ...

American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...